Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213
Child's Nervous System · 2024
DOI: 10.1007/s00381-024-06576-5 ↗Kurz gefasst
Fallbericht in der Zeitschrift Child's Nervous System, 2024. Verfasst von Ting-Chun Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-Ku, Sapporo, 060-8638, Japan. Hauptthemen laut MEDLINE: Moyamoya Disease, Ubiquitin-Protein Ligases, Proton Therapy, Adenosine Triphosphatases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-Ku, Sapporo, 060-8638, Japan.
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-Ku, Sapporo, 060-8638, Japan. uchinohr@gmail.com.
Zitieren
APA
Lin, T. C., Uchino, H., Ito, M., Yamaguchi, S., Ishi, Y., & Fujimura, M. (2024). Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213. Child's Nervous System. https://doi.org/10.1007/s00381-024-06576-5
Vancouver
Lin TC, Uchino H, Ito M, Yamaguchi S, Ishi Y, Fujimura M. Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213. Child's Nervous System. 2024. doi:10.1007/s00381-024-06576-5
BibTeX
@article{Lin2024,
author = {Lin, Ting-Chun and Uchino, Haruto and Ito, Masaki and Yamaguchi, Shigeru and Ishi, Yukitomo and Fujimura, Miki},
title = {Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213},
journal = {Child's Nervous System},
year = {2024},
doi = {10.1007/s00381-024-06576-5}
}
EUVIMED